Please login to the form below

licencing

This page shows the latest licencing news and features for those working in and with pharma, biotech and healthcare.

Chiesi's ultra-rare genetic disorder therapy wins European backing

Europe.”. Lamzede, which has been investigated in 33 patients, both adults and children, and the Italian group expects a licencing decision by the European Commission in the second quarter of 2018.

Latest news

Shire licences Parion dry eye drug in $535m deal

Shire has agreed a licencing deal with Parion Sciences for a dry eye disease drug that bolsters its ophthalmic portfolio, a priority area for the Irish group.
LEO Pharma picks up AZ skin disease drugs in $1bn deal

Gains rights to eczema and psoriasis treatments
Biomedical Catalyst funding 'must continue', says BIA

Moreover, another £1bn-plus has subsequently been raised by BMC-funded companies and academics "in the form of additional private finance, grant funding, via licencing or acquisition.".
Gilead's Harvoni gains NICE yes - but won't face funding delay

The commissioning body, which has control of around 40% of the total £105bn annual NHS budget in England, said that if Sovaldi was used by every patient in its licencing remit,
News in brief, March 07, 2007

Teikoku and Dermatrends have not disclosed whether they will enter into a licencing deal, but are optimistic about prospects for positive results from the development of this prototype.

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

Akari Therapeutics strengthens board

Grissinger (pictured right) has spent 22 years at Johnson &Johnson, holding positions of vice president and head of worldwide pharmaceutical licencing, as well as vice president and head of worldwide pharmaceutical

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Editorial Director – Medical Education: Neg

Account Manager- Manchester, Macclesfield or Glasgow: Negotiable

Associate Medical Director: Highly Competitive

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Account Executive – Medical Communications: Salary TBC

Account Director - Digital: Great salary and benefits

Account Director: Negotiable

Director Healthcare PR Communications: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 benefits

Account Manager, Healthcare Advertising: Salary TBC

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Director – Head of Public Affairs: Neg

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Experienced Editor, London, Medical Communications: Competitive package

Senior Medical Writer (Remote Working): Competitive Salary Offered

Lead Medical Copywriter, Healthcare Brand Communications, London: Excellent package

Account Director – Global Healthcare PR: Salary TBC

Scientific Team Lead: Competitive Salary

Project / Account Manager (Medical Education): Salary TBC

Senior Account Manager - Med Comms: Highly Competitive Salary &Benefits

Associate Medical Director: Salary TBC

Medical Strategic Director, Healthcare Advertising Agency: Salary TBC

Scientific Director: Highly Competitive Salary &Benefits

Subscribe to our email news alerts

PMHub

Add my company

Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies: Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?: Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds: A vision of Paris as Europe's leading hub for life sciences innovation...